Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 12, 2020 11:17 ET | Source: BioNTech SE

Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial

NEW YORK and MAINZ, GERMANY, Sept. 12, 2020 (GLOBE NEWSWIRE) -- NEW YORK and MAINZ, GERMANY, September 12 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) announced today that they...
September 11, 2020 07:00 ET | Source: AC Immune SA

AC Immune to Showcase Anti-Tau Portfolio at H.C. Wainwright 22nd Annual Global Investment Conference

LAUSANNE, Switzerland, Sept. 11, 2020 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative...
September 11, 2020 01:00 ET | Source: F. Hoffmann-La Roche Ltd

New data further reinforce Roche’s OCREVUS (ocrelizumab) as a highly effective treatment for people with multiple sclerosis

75% of patients with relapsing-remitting multiple sclerosis (RRMS) and suboptimal response to prior treatment had no evidence of disease activity two years after switching to OCREVUS in open-label...
September 10, 2020 12:04 ET | Source: Opthea Limited

Opthea Appoints US-Based Non-Executive Director

MELBOURNE, Australia, Sept. 10, 2020 (GLOBE NEWSWIRE) -- The directors of Opthea Limited (ASX:OPT), a clinical stage biopharmaceutical company developing a novel therapy to treat highly prevalent...
September 10, 2020 08:00 ET | Source: Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics Announces Appointment of Martin Babler to Board of Directors

SEATTLE, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de...
September 10, 2020 07:29 ET | Source: Fortune Business Insights

Breast Cancer Therapeutics Market to Reach USD 38,573.5 Million at 10.2% CAGR by 2026, supported by Implementation of Favourable Reimbursement Policies, says Fortune Business Insights

Pune, Sept. 10, 2020 (GLOBE NEWSWIRE) -- The increasing number of breast cancer cases all over the world is anticipated to boost the global breast cancer therapeutics market at promising rates,...
September 10, 2020 01:00 ET | Source: F. Hoffmann-La Roche Ltd

New data show Roche’s ENSPRYNG (satralizumab) significantly reduces severity and risk of relapse in neuromyelitis optica spectrum disorder (NMOSD)

ENSPRYNG lowered relapse severity in double-blind periods of SAkura Phase III studies. Pooled data from SAkura open-label extension (OLE) studies support continued effect of ENSPRYNG reducing risk of...
September 09, 2020 07:54 ET | Source: BioNTech SE

Pfizer und BioNTech veröffentlichen präklinische Daten zu mRNA-basiertem Impfstoffkandidaten gegen COVID-19

Die Immunisierung von nicht-humanen Primaten (Rhesusaffen) mit BNT162b2, einem nukleosidmodifizierten messenger RNA (modRNA)-Impfstoffkandidaten der für ein SARS-CoV-2-Spike-Glykoprotein kodiert,...
September 09, 2020 07:45 ET | Source: BioNTech SE

Pfizer and BioNTech Announce Data From Preclinical Studies of mRNA-Based Vaccine Candidate Against COVID-19

Immunization of non-human primates (rhesus macaques) with BNT162b2, a nucleoside-modified messenger RNA (modRNA) candidate that expresses the SARS-CoV-2 spike glycoprotein, resulted in strong...
September 09, 2020 06:15 ET | Source: BioNTech SE

Pfizer and BioNTech to Potentially Supply the EU with 200 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2

The proposed agreement is intended to provide a supply of 200 million doses and an option to purchase additional 100 million doses, with deliveries starting by the end of 2020, subject to regulatory...